New Enterprise Associates 13, L.P. 13D and 13G filings for PhaseBio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-04 4:42 pm Sale |
2022-11-03 | 13D | PhaseBio Pharmaceuticals, Inc. PHASQ |
New Enterprise Associates 13, L.P. | 0 0.000% |
-6,641,634 (Position Closed) |
Filing |